260 related articles for article (PubMed ID: 10750672)
1. Early onset baldness and prostate cancer risk.
Denmark-Wahnefried W; Schildkraut JM; Thompson D; Lesko SM; McIntyre L; Schwingl P; Paulson DF; Robertson CN; Anderson EE; Walther PJ
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):325-8. PubMed ID: 10750672
[TBL] [Abstract][Full Text] [Related]
2. Serum androgens: associations with prostate cancer risk and hair patterning.
Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
[TBL] [Abstract][Full Text] [Related]
3. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
[TBL] [Abstract][Full Text] [Related]
4. Male pattern baldness is not associated with established cardiovascular risk factors in the general population.
Ellis JA; Stebbing M; Harrap SB
Clin Sci (Lond); 2001 Apr; 100(4):401-4. PubMed ID: 11256978
[TBL] [Abstract][Full Text] [Related]
5. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels.
Faydaci G; Bilal E; Necmettin P; Fatih T; Asuman O; Uğur K
Aging Male; 2008 Dec; 11(4):189-92. PubMed ID: 19172550
[TBL] [Abstract][Full Text] [Related]
6. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue.
Rebora A
Arch Dermatol; 2001 Jul; 137(7):943-7. PubMed ID: 11453815
[TBL] [Abstract][Full Text] [Related]
7. Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
Salmon C; Mesidor M; Rousseau MC; Richard H; Weiss D; Spence AR; Parent ME
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):143-150. PubMed ID: 37851110
[TBL] [Abstract][Full Text] [Related]
8. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study.
Shahar E; Heiss G; Rosamond WD; Szklo M
Am J Epidemiol; 2008 Mar; 167(6):676-83. PubMed ID: 18208984
[TBL] [Abstract][Full Text] [Related]
9. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey.
Hawk E; Breslow RA; Graubard BI
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):523-7. PubMed ID: 10815699
[TBL] [Abstract][Full Text] [Related]
10. Reliability and validity of self-reported male balding patterns for use in epidemiologic studies.
Littman AJ; White E
Ann Epidemiol; 2005 Nov; 15(10):771-2. PubMed ID: 15949955
[TBL] [Abstract][Full Text] [Related]
11. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
Hayes VM; Severi G; Eggleton SA; Padilla EJ; Southey MC; Sutherland RL; Hopper JL; Giles GG
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):993-6. PubMed ID: 15824176
[TBL] [Abstract][Full Text] [Related]
12. Vasectomy and prostate cancer.
Lesko SM; Louik C; Vezina R; Rosenberg L; Shapiro S
J Urol; 1999 Jun; 161(6):1848-52; discussion 1852-3. PubMed ID: 10332451
[TBL] [Abstract][Full Text] [Related]
13. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
[TBL] [Abstract][Full Text] [Related]
14. Socio-economic and lifestyle factors associated with the risk of prostate cancer.
Lund Nilsen TI; Johnsen R; Vatten LJ
Br J Cancer; 2000 Apr; 82(7):1358-63. PubMed ID: 10755415
[TBL] [Abstract][Full Text] [Related]
15. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
[TBL] [Abstract][Full Text] [Related]
16. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking and risk of prostate cancer in middle-aged men.
Plaskon LA; Penson DF; Vaughan TL; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):604-9. PubMed ID: 12869398
[TBL] [Abstract][Full Text] [Related]
18. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
[TBL] [Abstract][Full Text] [Related]
19. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent associations between androgenetic alopecia and prostate cancer risk.
Muller DC; Giles GG; Sinclair R; Hopper JL; English DR; Severi G
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):209-15. PubMed ID: 23074289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]